Diagnostics Surgical Supply ApS: Financial statements 2022
CVR: 34472122
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Diagnostics Surgical Supply ApS (CVR 34472122) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,949,376 and a net result of DKK 2,067,920 compared with DKK 384,186 the year before. That is an increase of 132.5% compared with the year before. Equity in the 2022 report amounted to DKK 2,695,978. The solvency ratio was 67%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,949,376
- Profit/Loss
- DKK 2,067,920
- Equity
- DKK 2,695,978
- Total Assets
- DKK 4,026,674
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.9 mio. | 2.1 mio. | 2.7 mio. | 2 |
| 2021 | - | 1.7 mio. | 384 t. | 741 t. | 2 |
| 2020 | - | 1.4 mio. | 450 t. | 357 t. | 2 |
| 2019 | - | 1.2 mio. | -28 t. | -93 t. | 2 |
| 2018 | - | 1 mio. | -268 t. | -65 t. | 4 |
Official annual report
Keep an eye on Diagnostics Surgical Supply ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 13, 2022, Øernes Revision Registreret Revisionsaktieselskab has stepped down as auditor of Diagnostics Surgical Supply ApS.
On April 19, 2022, the company changed its name from STERILEAN ApS to Diagnostics Surgical Supply ApS.
About Diagnostics Surgical Supply ApS
Diagnostics Surgical Supply ApS is a Danish company of the type Anpartsselskab based in Jyllinge, founded in 2012. The company is registered under the industry Investering for egen regning. The company was previously named STERILEAN ApS and LJ MEDICAL SOLUTIONS ApS. The management consists of Leif Juhl-Jørgensen. The company is owned by Leif Juhl-Jørgensen and Anni Juhl-Jørgensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -77,382 and a net result of DKK -449,463 compared with DKK 193,230 the year before. Equity in the 2025 report amounted to DKK 1,616,902.